ARCHIVES

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

February 22, 2013

Rosenberg: Immunotherapy May Have Broad Potential

June 24, 2005

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

FDA’s Jane Henney

February 11, 1994

Multivitamin Use Doesn’t Impact Outcomes, Study Finds

September 24, 2010

No Constitutional Right To Experimental Drugs, Appeals Court Rules Against Abigail Alliance.

August 10, 2007